SHANNON BECKNER: Open Payments
NPI 1699215434 · SALEM, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,613 in 127 payments from 20 companies in 2025. Trend: 2023 $2,445 · 2024 $1,742 · 2025 $2,613
Food & beverage: $2,613
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $538 |
| Janssen Biotech, Inc. | 21 | $421 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $264 |
| PFIZER INC. | 8 | $186 |
| Regeneron Healthcare Solutions, Inc. | 5 | $142 |
| Boston Scientific Corporation | 1 | $123 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $111 |
| Aimmune Therapeutics, Inc. | 6 | $108 |
| Ipsen Biopharmaceuticals, Inc | 4 | $102 |
| Madrigal Pharmaceuticals | 5 | $88 |
Products named: TREMFYA, RINVOQ, XIFAXAN, DUPIXENT, VELSIPITY, LUX-Dx Insertable Cardiac Monitor, ZENPEP, IQIRVO.
Industry payments across VA — which companies pay providers there.
